Videregen Limited

This project will focus on developing a critical quality control (QC) method that will allow manufacturers to test and ensure the quality of an immune therapy (called BioThymus). The BioThymus therapy is designed to treat a life-threatening disease in infants. Children born without a thymus gland (called complete DiGeorge Syndrome or cDGS) have a poorly f...

This project will focus on the translation of world-leading UK research to deliver safety and efficacy data, to support development of a ground-breaking innovation that may transform organ transplantation by reducing/eliminating toxic immunosuppression, providing additional years of life, with reduced morbidities and cost. The project uses ground-breaking...

This project will focus on the translation of world-leading UK research into robust manufacturing processes ready for a future clinical trial to treat a life-threatening disease in infants. Babies born without a thymus gland (called complete DiGeorge Syndrome) have a fatally deficient immune system, and without treatment will die within 2-3 years. The pro...

no public description

"A bronchopleural fistula (BPF) is an abnormal hole between the airway (bronchus or trachea) and the chest cavity When a BPF develops, air that is breathed can travel through the abnormal hole and enter the chest cavity, which can result in life threatening infection. BPF is a rare but potentially fatal complication of lung surgery with high death rates. ...

This project seeks to create a niche, highly defensible, innovative regenerative medicine product with a global commercial potential of an estimated minmimum £70M annually This is aimed at patients with a life-threatening disease which would otherwise be unattractive had the same team of experts not already tested a clinical prototype which has shown prom...